Original text
Rate this translation
Your feedback will be used to help improve Google Translate
Home
Alembic Pharmaceuticals Limited
Press Release Apr 07 2026
Published Apr 7 2026
5 min read

Press Release Apr 07 2026

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 07, 2026, titled "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Dapagliflozin Tablets, 5 mg and 10 mg.".

View Attachment